Clarivate PLC (CLVT Quick QuoteCLVT - Free Report) reported $587.3 million in revenue for the quarter ended June 2026, representing a year-over-year decline of 5.5%. EPS of $0.19 for the same period compares to $0.18 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $587.06 million, representing a surprise of +0.04%. The company delivered an EPS surprise of +11.77%, with the consensus EPS estimate being $0.17.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Clarivate performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Life Sciences & Healthcare: $88.7 million versus the two-analyst average estimate of $93.25 million. The reported number represents a year-over-year change of -11.7%.
• Revenues- Academia & Government: $300.3 million versus the two-analyst average estimate of $294.8 million. The reported number represents a year-over-year change of -5.7%.
• Revenues- Intellectual Property: $198.3 million versus the two-analyst average estimate of $197.2 million. The reported number represents a year-over-year change of -2.1%.

View all Key Company Metrics for Clarivate here>>>

Shares of Clarivate have returned +11.1% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.